Impulse Dynamics CEO Simos Kedikoglou says a proposed rule from the US Centers for Medicare and Medicaid Services will help boost investment in research and development of breakthrough medical devices – and would be a good use of taxpayer dollars.
The CMS last month unveiled the long-awaited proposed rule that would give immediate national coverage for breakthrough devices. If finalized,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?